<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Urol Oncol</journal-id><journal-id journal-id-type="iso-abbrev">Urol Oncol</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Urologic oncology</journal-title></journal-title-group><issn pub-type="ppub">1078-1439</issn><issn pub-type="epub">1873-2496</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10257731</article-id><article-id pub-id-type="pmcid-ver">PMC10257731.1</article-id><article-id pub-id-type="pmcaid">10257731</article-id><article-id pub-id-type="pmcaiid">10257731</article-id><article-id pub-id-type="manuscript-id">NIHMS1853065</article-id><article-id pub-id-type="pmid">36529654</article-id><article-id pub-id-type="doi">10.1016/j.urolonc.2022.11.013</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1853065</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1853065</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Smoking cessation pharmacotherapy use during index hospital admission following cystectomy for bladder cancer: a retrospective cohort study</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Rapoport</surname><given-names initials="E">Eli</given-names></name><degrees>BS</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bjurlin</surname><given-names initials="MA">Marc A</given-names></name><degrees>DO, MSc</degrees><xref rid="A2" ref-type="aff">b</xref><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Furberg</surname><given-names initials="H">Helena</given-names></name><degrees>MSPH, PhD</degrees><xref rid="A4" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Donahue</surname><given-names initials="TF">Timothy F</given-names></name><degrees>MD</degrees><xref rid="A5" ref-type="aff">e</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Taneja</surname><given-names initials="SS">Samir S</given-names></name><degrees>MD</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bochner</surname><given-names initials="BH">Bernard H</given-names></name><degrees>MD</degrees><xref rid="A5" ref-type="aff">e</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ostroff</surname><given-names initials="JS">Jamie S</given-names></name><degrees>PhD</degrees><xref rid="A6" ref-type="aff">f</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Matulewicz</surname><given-names initials="RS">Richard S</given-names></name><degrees>MD, MSCI, MS</degrees><xref rid="A5" ref-type="aff">e</xref></contrib></contrib-group><aff id="A1"><label>a</label>Department of Urology, NYU Grossman School of Medicine; New York, NY</aff><aff id="A2"><label>b</label>Department of Urology, University of North Carolina at Chapel Hill</aff><aff id="A3"><label>c</label>Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill</aff><aff id="A4"><label>d</label>Department of Epidemiology &amp; Biostatistics, Memorial Sloan Kettering Cancer Center; New York, NY</aff><aff id="A5"><label>e</label>Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center; New York, NY</aff><aff id="A6"><label>f</label>Department of Psychology &amp; Behavioral Sciences, Memorial Sloan Kettering Cancer Center; New York, NY</aff><author-notes><corresp id="CR1"><bold>Address correspondence to:</bold> Richard Matulewicz, MD MSCI MS, Assistant Professor, Dept of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, <email>matulewr@mskcc.org</email>, 646-422-4547</corresp><fn fn-type="COI-statement" id="FN2"><p id="P36"><bold>Conflicts of interest:</bold> The authors have no conflicts of interest to disclose.</p></fn></author-notes><pub-date pub-type="ppub"><month>6</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>16</day><month>12</month><year>2022</year></pub-date><volume>41</volume><issue>6</issue><issue-id pub-id-type="pmc-issue-id">437893</issue-id><fpage>295.e1</fpage><lpage>295.e8</lpage><pub-history><event event-type="nihms-submitted"><date><day>27</day><month>11</month><year>2022</year></date></event><event event-type="pmc-release"><date><day>01</day><month>06</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>06</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 12:25:14.010"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1853065.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P1">To identify gaps in urologic oncology quality and evidence-based smoking cessation care by assessing how often smoking cessation pharmacotherapy (SCP) is given in the inpatient setting following cystectomy.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">The Premier Healthcare Database (PHD), a deidentified all-payer dataset, was used to generate nationally representative estimates of SCP receipt during hospitalization following cystectomy for patients with bladder cancer who smoke. Regressions were used to model associations between SCP receipt and patient- and hospital-level factors.</p></sec><sec id="S3"><title>Results:</title><p id="P3">Of the 21,624 patients who underwent cystectomy for bladder cancer, 3,676 patients (17.0%) were identified as current smokers, representing a weighted estimate of 16,063 admissions. Among these admissions, 27.9% of patients received SCP, the vast majority of which (91.5%) received exclusively nicotine replacement therapy. Rates of SCP receipt varied substantially across hospitals (median: 25.0%, IQR: 20.0&#8211;33.3, range: 0.0&#8211;60.0). Older age and black race (aOR=0.59, 95% CI: 0.42&#8211;0.82) were associated with lower odds of SCP receipt. Increased patient comorbidity score was associated with higher odds of SCP receipt (aOR=1.02, 95% CI: 1.01&#8211;1.03); specifically, chronic pulmonary disease, alcohol abuse, and depression were independently associated with SCP receipt. Hospital teaching status, bed capacity, and mean annual cystectomy volume were not associated with SCP receipt. SCP receipt was not associated with hospital length of stay nor 90-day readmission or mortality following cystectomy.</p></sec><sec id="S4"><title>Conclusions:</title><p id="P4">SCP is infrequently given to patients who smoke during their hospitalization following cystectomy for bladder cancer, representing a gap in quality urologic oncology care and a missed opportunity to effectively intervene with evidence-based treatment.</p></sec></abstract><kwd-group><kwd>Urinary bladder neoplasms</kwd><kwd>cystectomy</kwd><kwd>smoking cessation</kwd><kwd>smoking</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>